m****g 发帖数: 530 | 1 SEATTLE, March 23 /PRNewswire-FirstCall/ -- Oncothyreon Inc. (NASDAQ:ONTY)
today announced that
Merck Serono, a division of Merck KGaA of Darmstadt, Germany, and its U.S.
affiliate, EMD Serono, Inc.,
have temporarily suspended the worldwide clinical development program for
Stimuvax(R) (BLP25 liposomal
vaccine). The suspension is the result of a suspected unexpected serious
adverse reaction in a patient with
multiple myeloma participating in an exploratory clinical trial. This
decision was taken |
|